This is not the most recent version of the article. View current version (13 APR 2011)

Intervention Protocol

Surgical management for upper tract transitional cell carcinoma

  1. Bhavan Prasad Rai2,
  2. Nicholas P Cohen3,
  3. Mike Shelley4,
  4. James MO N'Dow5,
  5. Samuel McClinton6,
  6. Ghulam Nabi1,
  7. British Association of Urological Surgeons (BAUS), Section of Oncology7

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 21 APR 2008

DOI: 10.1002/14651858.CD007349

How to Cite

Author Information

  1. 1

    University of Aberdeen, Academic Urology Unit, Aberdeen, UK

  2. 2

    ARI, Urology, Aberdeen, UK

  3. 3

    urology, Aberdeen, UK

  4. 4

    Velindre NHS Trust, Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept, Cardiff, Wales, UK

  5. 5

    Aberdeen Royal Infirmary, NHS Trust, Ward 44, Aberdeen, Scotland, UK

  6. 6

    Aberdeen Royal Infirmary, Department of Urology, Ward 44, Aberdeen, UK

  7. 7

    London, UK

Publication History

  1. Published Online: 8 OCT 2008

SEARCH

This is not the most recent version of the article.View current version (13 Apr 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the best surgical management of upper tract transitional cell carcinoma.
The following comparisons are pre-stated:
1.Whether open radical nephroureterectomy is better than laparoscopic nephroureterectomy

2.Whether nephroureterectomy is better than conservative localised resection of ureter, where indicated

3. Whether open surgical resection (local or nephroureterectomy) is better than endoscopic resection and surveillance, where indicated

4.Whether open surgical method of handling lower end of ureter is better than endoscopic or laproscopic assisted methods